Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.
Huang, Fenglei
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers. [electronic resource] - Antimicrobial agents and chemotherapy Dec 2008 - 4300-7 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.00363-08 doi
Administration, Oral
Adult
Anti-HIV Agents--administration & dosage
Area Under Curve
Dose-Response Relationship, Drug
Drug Therapy, Combination
Humans
Male
Middle Aged
Reverse Transcriptase Inhibitors--administration & dosage
Ritonavir--administration & dosage
Treatment Outcome
Young Adult
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers. [electronic resource] - Antimicrobial agents and chemotherapy Dec 2008 - 4300-7 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.00363-08 doi
Administration, Oral
Adult
Anti-HIV Agents--administration & dosage
Area Under Curve
Dose-Response Relationship, Drug
Drug Therapy, Combination
Humans
Male
Middle Aged
Reverse Transcriptase Inhibitors--administration & dosage
Ritonavir--administration & dosage
Treatment Outcome
Young Adult